News for hackers. Stuff that matters.

A comment on Biohackers take aim at big pharma’s stranglehold on insulin. Parent comment

Re:Biohackers take aim at big pharma’s stranglehold on insulin by burkaman on Monday June 28, 2021 @02:48PM (#27665997)
I am arguing that there are no marginal projects at current profit levels, and that's why they can spend billions on stock buybacks. There is a point that lessening patent protections would cause companies to cut back, but we are not at that point.
[ Parent | on HN ]
Re:Biohackers take aim at big pharma’s stranglehold on insulin by gruez on Monday June 28, 2021 @07:29PM (#27669686)
>I am arguing that there are no marginal projects at current profit levels, and that's why they can spend billions on stock buybacks

How does the act of buybacks imply that there are no marginal projects?

[ Parent | on HN ]